Followers | 752 |
Posts | 18829 |
Boards Moderated | 1 |
Alias Born | 02/28/2007 |
Sunday, November 22, 2020 8:25:56 AM
so yes you're quite correct that chnc with the os where it is needs to start generating millions or it's not going anywhere. the saving grace here is that there are NO death spiral convertible notes they've been paid off.
it's to bad these idiots didn't realize what they were doing to their valuation when they gave themselves billions in restricted shares. where the F do they actually think they're going to sell these shares pps wise? it's not going to be very high lolol. they could've given themselves the same amounts in 100's of millions and had this stock trading in the pennies. it's this overall stupidity in the pinks that drives me nuts.
we have a growing little co here with no debt and possibilities good ones going forward with an absolute F'ED share structure.
can chnc see .003's .004's perhaps .005's? yes. see .01 that's an 87m valuation so you would need something BIG very BIG to drop.
as a trade chnc is excellent and will continue to be so as long as the os stays firmly unchanged.
this covid treatment needs to hit the market NOW. the treatment has potential but needs a partner and mass produced NOW. If there truly is potential in it and they get a big partner to back it like there have been hints about gilead sciences... there is your catalyst to break not only .0016 but most likely .0036. if gilead believes so will the market.
to all think about the trade why you're in it and most importantly when to get the F out. enjoy your Sunday everyone PEACE
find me on Twitter to follow what I'm really trading on. post charts etc and will answer questions. you can make money without being nasty so be a positive in our trading community. now go make some money!
Recent CBIH News
- FINRA Announces Approval for Corporate Name Change From "China Infrastructure Construction Corp." to "Cannabis Bioscience International Holdings" And Ticker Symbol Change from "CHNC" to "CBIH". • InvestorsHub NewsWire • 08/21/2023 01:00:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM